Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Nidhi Singh, Mayank Handa, Vanshikha Singh, Prashant Kesharwani & Rahul Shukla. (2022) Lymphatic targeting for therapeutic application using nanoparticulate systems. Journal of Drug Targeting 30:10, pages 1017-1033.
Read now
Read now
Rania F. Ahmed, Maha Nasr, Marawan Abd Elbaset, Alyaa Farouk Hessin, Omar A. H. Ahmed-Farid, Nermeen M. Shaffie & Marwa E. Shabana. (2022) Combating hematopoietic and hepatocellular abnormalities resulting from administration of cisplatin: role of liver targeted glycyrrhetinic acid nanoliposomes loaded with amino acids. Pharmaceutical Development and Technology 27:9, pages 925-941.
Read now
Read now
Takayuki Yoshida, Hiroyuki Kojima, Kazuhiro Sako & Hiromu Kondo. (2022) Drug delivery to the intestinal lymph by oral formulations. Pharmaceutical Development and Technology 27:2, pages 175-189.
Read now
Read now
Swapna Poudwal, Ambikanandan Misra & Pravin Shende. (2021) Role of lipid nanocarriers for enhancing oral absorption and bioavailability of insulin and GLP-1 receptor agonists. Journal of Drug Targeting 29:8, pages 834-847.
Read now
Read now
N. Basaran Mutlu-Agardan & S. Han. (2021) In vitro and in vivo evaluations on nanoparticle and phospholipid hybrid nanoparticles with absorption enhancers for oral insulin delivery. Pharmaceutical Development and Technology 26:2, pages 157-166.
Read now
Read now
Yuanyuan Wang, Chao Pi, Xianhu Feng, Yi Hou, Ling Zhao & Yumeng Wei. (2020) The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs. International Journal of Nanomedicine 15, pages 6295-6310.
Read now
Read now
Mitali H. Patel, Veenu P. Mundada & Krutika K. Sawant. (2019) Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia. Drug Development and Industrial Pharmacy 45:8, pages 1242-1257.
Read now
Read now
Jin Ren, Zhengjie Fang, Liqun Jiang & Qian Du. (2017) Quercetin-containing self-assemble proliposome preparation and evaluation. Journal of Liposome Research 27:4, pages 335-342.
Read now
Read now
Yue Yuan Luo, Xiang Yuan Xiong, Yuan Tian, Zi Ling Li, Yan Chun Gong & Yu Ping Li. (2016) A review of biodegradable polymeric systems for oral insulin delivery. Drug Delivery 23:6, pages 1882-1891.
Read now
Read now
Krutika K. Sawant, Mitali H. Patel & Krishna Patel. (2016) Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro–in vivo evaluations. Drug Development and Industrial Pharmacy 42:5, pages 758-768.
Read now
Read now
Qingqing Cai, Xinxian Deng, Zhongdong Li, Dianyun An, Teng Shen & Mingkang Zhong. (2016) Effects of lipid vehicle and P-glycoprotein inhibition on the mesenteric lymphatic transport of paclitaxel in unconscious, lymph duct-cannulated rats. Drug Delivery 23:1, pages 147-153.
Read now
Read now
Neha N Parayath, Hayley Nehoff, Philipp Müller, Sebastien Taurin & Khaled Greish. (2015) Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery – dual uptake through enterocytes and M-cells. International Journal of Nanomedicine 10, pages 4653-4667.
Read now
Read now
Vijaykumar Nekkanti, Natarajan Venkatesan, Zhijun Wang & Guru V. Betageri. (2015) Improved oral bioavailability of valsartan using proliposomes: design, characterization and in vivo pharmacokinetics. Drug Development and Industrial Pharmacy 41:12, pages 2077-2088.
Read now
Read now
Hyeongmin Kim, Ilkyeong Seong, Jieun Ro, Seong-Ha Hwang, Gyiae Yun & Jaehwi Lee. (2015) Enhanced association of probucol with chylomicron by pharmaceutical excipients: an in vitro study. Drug Development and Industrial Pharmacy 41:7, pages 1073-1079.
Read now
Read now
Shilpa Chaudhary, Tarun Garg, R. S. R. Murthy, Goutam Rath & Amit K. Goyal. (2014) Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. Journal of Drug Targeting 22:10, pages 871-882.
Read now
Read now
Indu Singh, Rajan Swami, Wahid Khan & Ramakrishna Sistla. (2014) Lymphatic system: a prospective area for advanced targeting of particulate drug carriers. Expert Opinion on Drug Delivery 11:2, pages 211-229.
Read now
Read now
Yaw-Bin Huang, Ming-Jun Tsai, Pao-Chu Wu, Yi-Hung Tsai, Yi-Hsin Wu & Jia-You Fang. (2011) Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. Journal of Drug Targeting 19:8, pages 709-718.
Read now
Read now
Articles from other publishers (48)
Yang-Bao Miao, Tianxing Xu, Ying Gong, Anmei Chen, Liang Zou, Tao Jiang & Yi Shi. (2023) Cracking the intestinal lymphatic system window utilizing oral delivery vehicles for precise therapy. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Darshan Petkar Ramachandra & Preethi Sudheer. (2023) Self-micro Emulsifying Drug Delivery via Intestinal Lymphatics: A Lucrative
Approach to Drug Targeting. Pharmaceutical Nanotechnology 11:3, pages 238-264.
Crossref
Crossref
Xiaohan Sun, Angel Tan & Ben J. Boyd. (2022) Magnetically‐activated lipid nanocarriers in biomedical applications: A review of current status and perspective. WIREs Nanomedicine and Nanobiotechnology 15:3.
Crossref
Crossref
Ardiyah Nurul Fitri Marzaman, Tri Puspita Roska, Sartini Sartini, Rifka Nurul Utami, Sulistiawati Sulistiawati, Cindy Kristina Enggi, Marianti A. Manggau, Latifah Rahman, Venkatram Prasad Shastri & Andi Dian Permana. (2023) Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes. Antibiotics 12:5, pages 822.
Crossref
Crossref
Sushil Yadaorao Raut, Kengyen Fu, Huang Taichun, Avinash Gahane, Dasharath Chaudhari, Varun Kushwah, Renuka Suresh Managuli, Aswathi R. Hegde, Sanyog Jain, Guruprasad Kalthur, Manjunath Bandu Joshi, Hsin-I. Chang, Niann-Tzyy Dai & Srinivas Mutalik. (2023) Engineered Nano-carrier systems for the oral targeted delivery of follicle stimulating Hormone: Development, characterization, and, assessment of in vitro and in vivo performance and targetability. International Journal of Pharmaceutics 637, pages 122868.
Crossref
Crossref
Simranjeet KaurDilpreet Singh. (2023) A Sojourn on Liposomal Delivery System: Recent Advances and Future Prospects. ASSAY and Drug Development Technologies 21:2, pages 48-64.
Crossref
Crossref
Menna M. Abdellatif, Sara Mohamed Ahmed, Mohamed A. El-Nabarawi & Mahmoud Teaima. (2022) Oral Bioavailability Enhancement of Vancomycin Hydrochloride with Cationic Nanocarrier (Leciplex): Optimization, In Vitro, Ex Vivo, and In Vivo Studies. Scientia Pharmaceutica 91:1, pages 1.
Crossref
Crossref
Hussam I. Kutbi, Hani Z. Asfour, Ahmed K. Kammoun, Alaa Sirwi, Simona Cavalu & Heba A. Gad. (2021) Optimization of Hyaluronate-Based Liposomes to Augment the Oral Delivery and the Bioavailability of Berberine. Materials 14:19, pages 5759.
Crossref
Crossref
Priyanka Pandya, Prabhanjan Giram, Ritesh P. Bhole, Hsin-I Chang & Sushil Y. Raut. (2021) Nanocarriers based oral lymphatic drug targeting: Strategic bioavailability enhancement approaches. Journal of Drug Delivery Science and Technology 64, pages 102585.
Crossref
Crossref
Zichen Zhang, Yi Lu, Jianping Qi & Wei Wu. (2021) An update on oral drug delivery via intestinal lymphatic transport. Acta Pharmaceutica Sinica B 11:8, pages 2449-2468.
Crossref
Crossref
Suryanarayana Polaka, Kiran Katrajkar, D.V. Siva Reddy, Havish Shukla, Basel Arafat & Rakesh Kumar Tekade. 2021. Biopharmaceutics and Pharmacokinetics Considerations. Biopharmaceutics and Pharmacokinetics Considerations
567
599
.
Shan Jiang, Tian-Tian Zhang, Pei-Xu Cong, Jie Xu, Chang-Hu Xue, Xiao-Ming Jiang & Yu-Ming Wang. (2020) Comparative study on the digestion and absorption characteristics of n-3 LCPUFA-enriched phospholipids in the form of liposomes and emulsions. Food Research International 137, pages 109428.
Crossref
Crossref
Keisuke Konishi, Lei Du, Grégory Francius, Michel Linder, Tomoaki Sugawara, Hideyuki Kurihara & Koretaro Takahashi. (2020) Lipid Composition of Liposomal Membrane Largely Affects Its Transport and Uptake through Small Intestinal Epithelial Cell Models. Lipids 55:6, pages 671-682.
Crossref
Crossref
Wing-Fu Lai, Wing-Tak Wong & Andrey L. Rogach. (2020) Molecular Design of Layer-by-Layer Functionalized Liposomes for Oral Drug Delivery. ACS Applied Materials & Interfaces 12:39, pages 43341-43351.
Crossref
Crossref
Saurabh Shrivastava, Anshita Gupta & Chanchal Deep Kaur. (2020) The Epitome of Novel Techniques and Targeting Approaches in Drug Delivery for Treating Lymphatic Filariasis. Current Drug Targets 21:12, pages 1250-1263.
Crossref
Crossref
Wenjuan Liu, Dong Li, Zirong Dong, Kaiheng Liu, Haisheng He, Yi Lu, Wei Wu, Qinghua Li, Li Gan & Jianping Qi. (2020) Insight into the in vivo translocation of oral liposomes by fluorescence resonance energy transfer effect. International Journal of Pharmaceutics 587, pages 119682.
Crossref
Crossref
Pavel Ryšánek, Tomáš Grus, Martin Šíma & Ondřej Slanař. (2020) Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties. Pharmaceutical Research 37:9.
Crossref
Crossref
Yi Wang & Wing-Fu Lai. 2020. Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications. Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications
393
409
.
Haisheng He, Yi Lu, Jianping Qi, Quangang Zhu, Zhongjian Chen & Wei Wu. (2019) Adapting liposomes for oral drug delivery. Acta Pharmaceutica Sinica B 9:1, pages 36-48.
Crossref
Crossref
Rakesh P. Patel, Pranav Shah, Kalyani Barve, Nikunjana Patel & Jaimini Gandhi. 2019. Novel Drug Delivery Technologies. Novel Drug Delivery Technologies
121
149
.
Eunhye Yang, Hyunjong Yu, Jun-Young Park, Kyung-Min Park & Pahn-Shick Chang. (2018)
Microfluidic Preparation of Liposomes Using Ethyl Acetate/
n
-Hexane Solvents as an Alternative to Chloroform
. Journal of Chemistry 2018, pages 1-6.
Crossref
Crossref
Vivek Patel, Rohan Lalani, Denish Bardoliwala, Saikat Ghosh & Ambikanandan Misra. (2018) Lipid-Based Oral Formulation Strategies for Lipophilic Drugs. AAPS PharmSciTech 19:8, pages 3609-3630.
Crossref
Crossref
Rajan Jog & Diane J. Burgess. 2018. Fundamentals of Nanoparticles. Fundamentals of Nanoparticles
279
342
.
C. R Bora, R. H. Prabhu & V. B. Patravale. (2017) LYMPHATIC DELIVERY: CONCEPT, CHALLENGES AND APPLICATIONS. INDIAN DRUGS 54:08, pages 5-22.
Crossref
Crossref
Martina Di Francesco, Christian Celia, Rosita Primavera, Nicola D’Avanzo, Marcello Locatelli, Massimo Fresta, Felisa Cilurzo, Cinzia Anna Ventura, Donatella Paolino & Luisa Di Marzio. (2017) Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy. International Journal of Pharmaceutics 528:1-2, pages 18-32.
Crossref
Crossref
Jean Cornier, Andrew Owen, Arno Kwade & Marcel Van de VoordeMarco Siccardi, Alessandro Schipani & Andrew Owen. 2017. Pharmaceutical Nanotechnology: Innovation and Production. Pharmaceutical Nanotechnology: Innovation and Production
379
402
.
Ceyda T. Sengel-Turk, Mehmet Gumustas, Bengi Uslu & Sibel A. Ozkan. 2017. Nano- and Microscale Drug Delivery Systems. Nano- and Microscale Drug Delivery Systems
165
195
.
Hyeji Ahn & Ji-Ho Park. (2016) Liposomal delivery systems for intestinal lymphatic drug transport. Biomaterials Research 20:1.
Crossref
Crossref
Sandy Ong, Long Ming, Kah Lee & Kah Yuen. (2016) Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes. Pharmaceutics 8:3, pages 25.
Crossref
Crossref
Qiuhong Yang & Laird Forrest. 2016. Drug Delivery. Drug Delivery
503
548
.
Arvind Thakkar, Sushma Chenreddy, Jeffrey Wang & Sunil Prabhu. (2015) Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles. Cell & Bioscience 5:1.
Crossref
Crossref
Sophia Yui Kau Fong, Martin Brandl & Annette Bauer-Brandl. (2015) Phospholipid-based solid drug formulations for oral bioavailability enhancement: A meta-analysis. European Journal of Pharmaceutical Sciences 80, pages 89-110.
Crossref
Crossref
Indu Singh, Rajan Swami, Wahid Khan & Ramakrishna Sistla. 2014. Focal Controlled Drug Delivery. Focal Controlled Drug Delivery
429
458
.
Deepa Mishra, Justin R. Hubenak & Anshu B. Mathur. (2013) Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy. Journal of Biomedical Materials Research Part A 101:12, pages 3646-3660.
Crossref
Crossref
Frank BoehmMisagh Alipour, Abdelwahab Omri & Zacharias Suntres. 2013. Nanomedical Device and Systems Design. Nanomedical Device and Systems Design
455
490
.
Kaushik Thanki, Rahul P. Gangwal, Abhay T. Sangamwar & Sanyog Jain. (2013) Oral delivery of anticancer drugs: Challenges and opportunities. Journal of Controlled Release 170:1, pages 15-40.
Crossref
Crossref
Cynthia Lopes Ferreira, Fernando Antônio Mauad de Abreu, Gerluza Aparecida Borges Silva, Frank Ferreira Silveira, Luana Beatriz Araújo Barreto, Tony de Paiva Paulino, Melissa Nunes Miziara & José Bento Alves. (2013) TGF-β1 and BMP-4 carried by liposomes enhance the healing process in alveolar bone. Archives of Oral Biology 58:6, pages 646-656.
Crossref
Crossref
Hyeongmin Kim, Yeongseok Kim & Jaehwi Lee. (2013) Liposomal formulations for enhanced lymphatic drug delivery. Asian Journal of Pharmaceutical Sciences 8:2, pages 96-103.
Crossref
Crossref
Hyo-Kyung Han, Hyun-Jae Shin & Dong Hoon Ha. (2012) Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. European Journal of Pharmaceutical Sciences 46:5, pages 500-507.
Crossref
Crossref
Shih-Pin Hsu & I-Ming Chu. (2012) Design of polyanionic nanocarriers based on modified poly (aspartic acid)s for oral administration: synthesis and characterization. Journal of Polymer Research 19:7.
Crossref
Crossref
Shuang Cai, Qiuhong Yang, Taryn R. Bagby & M. Laird Forrest. (2011) Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Advanced Drug Delivery Reviews 63:10-11, pages 901-908.
Crossref
Crossref
Sravan Penchala, Anh‐Nhan Pham, Ying Huang & Jeffrey Wang. 2011. Oral Bioavailability. Oral Bioavailability
343
354
.
Ji-Hoon Choi & Yong-Bok Lee. (2010) Nano-sized Drug Carriers and Key Factors for Lymphatic Delivery. Journal of Pharmaceutical Investigation 40:spc, pages 75-82.
Crossref
Crossref
Emilie Roger, Frederic Lagarce, Emmanuel Garcion & Jean-Pierre Benoit. (2010) Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine 5:2, pages 287-306.
Crossref
Crossref
Abu Bakar Abdul Majeed, Rosa E. V. Pereira, Tommy B. Julianto & Kah H. Yuen. (2010) Enhanced oral cefotaxime sodium bioavailability after administration of cefotaxime-loaded Eudragit S100 nanoparticles and its influence on the lymphatic transport. Enhanced oral cefotaxime sodium bioavailability after administration of cefotaxime-loaded Eudragit S100 nanoparticles and its influence on the lymphatic transport.
Sharon Sheue Nee Ling, Kah Hay Yuen, Enrico Magosso & Susan Anne Barker. (2009) Oral bioavailability enhancement of a hydrophilic drug delivered via folic acid-coupled liposomes in rats. Journal of Pharmacy and Pharmacology 61:4, pages 445-449.
Crossref
Crossref
Svetlana Golocorbin-Kon, Momir Mikov, Mousab Arafat, Zika Lepojevic, Ivan Mikov, Majda Sahman-Zaimovic & Zdenko Tomic. (2009) Cefotaxime pharmacokinetics after oral application in the form of 3α,7α-dihydroxy-12-keto-5β-cholanate microvesicles in rat. European Journal of Drug Metabolism and Pharmacokinetics 34:1, pages 31-36.
Crossref
Crossref
Xiang Yuan Xiong, Yu Ping Li, Zi Ling Li, Chun Li Zhou, Kam Chiu Tam, Zhi Yong Liu & Guo Xiu Xie. (2007) Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. Journal of Controlled Release 120:1-2, pages 11-17.
Crossref
Crossref